MetaCap

Alto Neuroscience Statistics

NYSE: ANROHealth CareBiotechnology: Pharmaceutical PreparationsUSD

25.37-1.14 (-4.30%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Alto Neuroscience by the numbers

Alto Neuroscience has a market capitalization of $1.02 billion based on 40.11M shares outstanding. With trailing EPS of $-2.32, Alto Neuroscience is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 0.8% below its 50-day average and 1.5% above its 200-day average.

Average daily trading volume is 614.92K shares, or about $15.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ANRO valuation vs. peer median

ANRO compared with the median of 8 peer companies
MetricANROPeer medianDifference
Market cap$1.02B$1.01B+1%
Avg. volume614.92K880.51K-30%

Peer median across 8 companies: CTY, NKTR, OMER, JBIO, SPTX, CYRX, KARD, MLTX.

Valuation

Price and trading

Previous close
26.51
Open
25.76
Day range
24.40 – 26.48
52-week range
12.51 – 37.48
52-week change
+91.47%
Beta
—
Volume
522.53K

Dividends and events

Annual dividend
None
Next earnings date
Nov 10, 2026

Additional statistics

Market Cap
1.02B
Forward Pe
-8.58
Eps
-2.32
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
37.48
Week52 Low
12.51
Avg Volume
614.92K
Shares Outstanding
40.11M
Ma50
25.58
Ma200
25.00
Earnings Date
Nov 10, 2026
Pct From52w High
-32.31%
Pct From52w Low
102.80%

Related